A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

[1]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[2]  B. Daniele,et al.  Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma , 2008 .

[3]  J. Marrero,et al.  Diagnosis and treatment of hepatocellular carcinoma. , 2008, Gastroenterology.

[4]  L. Meng,et al.  Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma , 2007, Clinical Cancer Research.

[5]  J. Prieto,et al.  New therapies for hepatocellular carcinoma , 2006, Oncogene.

[6]  J. Nemunaitis,et al.  Herpes simplex virus 1 (HSV-1) for cancer treatment , 2006, Cancer Gene Therapy.

[7]  E. Taniguchi,et al.  Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma. , 2006, Gastroenterology.

[8]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[9]  Sanjiv S. Gambhir,et al.  Gene therapy imaging in patients for oncological applications , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  J. Barrio,et al.  Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. , 2005, Gastroenterology.

[11]  G. Palù,et al.  Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. , 2005, Journal of hepatology.

[12]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[13]  G. Vassaux,et al.  Use of suicide genes for cancer gene therapy: study of the different approaches , 2004, Expert opinion on biological therapy.

[14]  J. Prieto,et al.  Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. , 2003, Human gene therapy.

[15]  B. Sangro,et al.  Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. , 2003, Current gene therapy.

[16]  J. Barrio,et al.  A fully automated one pot synthesis of 9-(4-[18F]fluoro-3-hydroxymethylbutyl) guanine for gene therapy studies. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[17]  L. Mohr,et al.  Gene therapy for malignant liver disease , 2002, Expert opinion on biological therapy.

[18]  H. Yeh,et al.  Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[20]  S. Hirono,et al.  Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. , 2001, Cancer research.

[21]  J. Prieto,et al.  Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model , 2000, Cancer Gene Therapy.

[22]  J. Prieto,et al.  Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. , 2000, Journal of hepatology.

[23]  H. Yoshiji,et al.  Cancer gene therapy with HSV‐tk/GCV system depends on t‐cell‐mediated immune responses and causes apoptotic death of tumor cells In vivo , 1999 .

[24]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[25]  Y. Kan,et al.  Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Klatzmann,et al.  A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. , 1997, Human gene therapy.

[27]  J. Prieto,et al.  Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma. , 1997, Human gene therapy.

[28]  J. Wilson,et al.  Adenoviruses as gene-delivery vehicles. , 1996, The New England journal of medicine.

[29]  C. Qian,et al.  Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus‐mediated gene transfer of herpes simplex virus thymidine kinase , 1995, Hepatology.

[30]  S. Freeman,et al.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. , 1993, Cancer research.

[31]  R. Boehme,et al.  Antiviral activity and mechanism of action of ganciclovir. , 1988, Reviews of infectious diseases.

[32]  F. Moolten.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. , 1986, Cancer research.

[33]  L Lasagna,et al.  Adverse drug reactions. A critical review. , 1975, JAMA.

[34]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[35]  V. Kähäri,et al.  Efficient infection of tumor endothelial cells by a capsid-modified adenovirus , 2006, Gene Therapy.

[36]  Cheng Qian,et al.  Tracing transgene expression in cancer gene therapy: a requirement for rational progress in the field. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[37]  E. B. Butler,et al.  Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report. , 2001, International journal of radiation oncology, biology, physics.